SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-426678
Filing Date
2016-01-11
Accepted
2016-01-11 17:16:54
Documents
5
Period of Report
2016-01-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d120894d8k.htm 8-K 68549
2 EX-2.1 d120894dex21.htm EX-2.1 602378
3 EX-4.1 d120894dex41.htm EX-4.1 19771
4 EX-10.1 d120894dex101.htm EX-10.1 93163
5 EX-10.2 d120894dex102.htm EX-10.2 14317
  Complete submission text file 0001193125-16-426678.txt   799495
Mailing Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015 224-940-2000
Baxalta Inc (Filer) CIK: 0001620546 (see all company filings)

IRS No.: 471869689 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36782 | Film No.: 161337030
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences